PMID: 15220193Jun 29, 2004Paper

Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4

Diabetes
Norihiko OgawaT Maki

Abstract

Treatment of overtly diabetic NOD mice with anti-lymphocyte serum (ALS), a polyclonal anti-T-cell antibody, abrogates autoimmunity and achieves partial clinical remission. Here we investigated whether the addition of exendin-4, a hormone that stimulates insulin secretion and beta-cell replication and differentiation, improves induction of remission by ALS. Transient treatment of overtly diabetic NOD mice with ALS and exendin-4 achieved complete remission in 23 of 26 mice (88%) within 75 days, accompanied by progressive normalization of glucose tolerance, improved islet histology, increased insulin content in the pancreas, and insulin release in response to a glucose challenge. Syngeneic islets transplanted into mice cured by treatment with ALS plus exendin-4 remained intact, and cotransfer of lymphocytes from cured mice delayed diabetes induction by adoptive transfer, suggesting the long-lasting presence of autoimmune regulatory cells. Although ALS alone also achieved reversal of diabetes, the frequency of remission was low (40%). No treatment or exendin-4 alone failed to produce remission. These results show that exendin-4 synergistically augments the remission-inducing effect of ALS. The addition of beta-cell growth factors, ...Continue Reading

References

Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T MakiJ Porter
Oct 1, 1986·Jikken dobutsu. Experimental animals·M Harada, S Makino
Jun 11, 1981·The New England Journal of Medicine·G F Cahill, H O McDevitt
Jan 1, 1980·Jikken dobutsu. Experimental animals·S MakinoY Tochino
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·L ChatenoudJ F Bach
Jun 1, 1997·European Journal of Clinical Investigation·J F ToddS R Bloom
Mar 23, 2002·Experimental Biology and Medicine·Claudia PastoraleHéctor Chemes
May 31, 2002·The New England Journal of Medicine·Kevan C HeroldJeffrey A Bluestone
Aug 24, 2002·Endocrinology·Anandwardhan A HardikarBernard E Tuch
Oct 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Jamileh MovassatAlberto Hayek
Nov 1, 2002·The Journal of Biological Chemistry·Yazhou LiDaniel J Drucker
Jun 24, 2003·Nature Biotechnology·David HessMickie Bhatia
Nov 15, 2003·Science·Shohta KodamaDenise L Faustman

❮ Previous
Next ❯

Citations

May 10, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Kristi D SilverBraxton D Mitchell
Dec 3, 2005·Pharmaceutical Research·Pleunie P M RoodMassimo Trucco
Jul 7, 2012·Current Diabetes Reports·Claire M Issa, Sami T Azar
Aug 9, 2013·Current Diabetes Reports·Yong WangJose Oberholzer
Jun 11, 2008·Immunologic Research·Bo Wang, Roland Tisch
Dec 5, 2008·Immunologic Research·Bo Wang, Roland Tisch
Oct 9, 2012·Cellular & Molecular Immunology·Benjamin K NtiTatiana D Zorina
Jul 9, 2005·Nature Biotechnology·Susan Bonner-Weir, Gordon C Weir
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Simona Cernea, Kevan C Herold
Dec 13, 2005·Nature Reviews. Drug Discovery·Jan van der Greef, Robert N McBurney
Dec 2, 2004·Nature Reviews. Immunology·Bart O RoepMatthias von Herrath
Jul 21, 2007·Nature Reviews. Immunology·Lucienne Chatenoud, Jeffrey A Bluestone
Nov 6, 2007·Nature Reviews. Immunology·Matthias von HerrathKevan Herold
Dec 14, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Meng-Ju LiuHee-Sook Jun
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria KoulmandaTerry B Strom
Jan 11, 2007·The Journal of Experimental Medicine·Kristin V TarbellRalph M Steinman
May 25, 2005·Transplantation·A M James ShapiroEdmond A Ryan
Mar 7, 2012·Cold Spring Harbor Perspectives in Medicine·Lukas T JekerJeffrey A Bluestone
May 26, 2010·The Journal of Pharmacology and Experimental Therapeutics·Byung-Joon KimJosephine M Egan
Jul 26, 2011·Clinical & Developmental Immunology·Brett PhillipsNick Giannoukakis
Jan 5, 2005·The Journal of Clinical Investigation·Massimo Trucco
Dec 8, 2007·Endocrinology·Irene HadjiyanniDaniel J Drucker
May 19, 2012·PloS One·Maria KoulmandaTerry B Strom
May 23, 2012·PloS One·Abdoreza Davoodi-SemiromiMark Atkinson
May 9, 2006·Treatments in Endocrinology·Wayne Truong, A M James Shapiro
Aug 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Maria KoulmandaTerry B Strom
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Chunyan ZhangDefu Zeng
May 7, 2013·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Jeremy PettusSteven Edelman
Aug 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Rhonda D WidemanTimothy J Kieffer
Feb 1, 2007·Current Opinion in Organ Transplantation·Michael F Crutchlow, Doris A Stoffers
Oct 30, 2010·Expert Opinion on Biological Therapy·Michael J Riedel, Timothy J Kieffer
Oct 22, 2013·Metabolism: Clinical and Experimental·Young-Sun Lee, Hee-Sook Jun
Dec 25, 2012·Trends in Endocrinology and Metabolism : TEM·Joel F Habener, Violeta Stanojevic

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.